Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001543256-21-000001
Filing Date
2021-01-14
Accepted
2021-01-14 16:49:55
Documents
1
Effectiveness Date
2021-01-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11874
  Complete submission text file 0001543256-21-000001.txt   12989
Mailing Address ATTN: WILLIAM HEARL, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD 20850
Business Address ATTN: WILLIAM HEARL, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD 20850 301-728-0860
Immunomic Therapeutics, Inc. (Filer) CIK: 0001543256 (see all company filings)

EIN.: 203878827 | State of Incorp.: DE | Fiscal Year End: 1212
Type: D/A | Act: 33 | File No.: 021-361369 | Film No.: 21529410